Company / Current Liabilities
Twist Bioscience Corp Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$91.4M
FY2025
5-year range
$63.1M / $91.4M
FY2021-FY2025
Trend
+28.7%
vs FY2024
Sector context
#104 of 215
Health Care
What the data says
At $91M, Twist Bioscience Corp's current liabilities ranks #112 of 215 in the Health Care sector. Current Liabilities returned to growth in FY2025 after 2 years of decline, reaching $91M.
Based on SEC 10-K filings.
$91M in FY2025 with a 5-year CAGR of +20.5%.
Increased from $73M to $91M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +0.3%
- 5-Year CAGR
- +20.5%
- 10-Year CAGR
- -
Sector benchmark
#112 of 215 in Health CareTop 52% of 215This company $91.4M Sector average $1.6B
▼
-94.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.5%, indicating consistent growth.
- In FY2025, current liabilities increased 28.7% year-over-year.
- Ranks #104 out of 215 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $91.4M | +28.7% |
| FY2024 | $71.0M | -3.2% |
| FY2023 | $73.3M | -19.1% |
| FY2022 | $90.7M | +43.8% |
| FY2021 | $63.1M | +75.0% |
| FY2020 | $36.0M | +18.7% |
| FY2019 | $30.4M | +63.7% |
| FY2018 | $18.5M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026